Patterns of antihypertensive medication use in hemodialysis patients

American Journal of Health-System Pharmacy

Volumn 61, Issue 14, 2004, Pages 1473-1478

  Rahman, Mahboob ^a,c   Griffin, Valerie ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UHC ^*

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium antagonists; Compliance; Costs; Dialysis; Drug use; Hypertension; Hypotensive agents; Patients; Sympatholytic agents

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; MINOXIDIL; RESERPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; COST; DATA BASE; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INTERVIEW; KIDNEY DISEASE; MALE; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; ATTITUDE TO HEALTH; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; ECONOMICS; MIDDLE AGED; PATIENT COMPLIANCE; RENAL REPLACEMENT THERAPY;

ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RENAL DIALYSIS;

EID: 5144235178     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.14.1473     Document Type: Article

References (35)

1. Mailloux LU. Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes. Semin Nephrol. 2001; 21:146-56.
2. Rahman M, Smith MC. Hypertension in hemodialysis patients. Curr Hypertens Rep. 2001; 3:496-502.
3. Agarwal R, Nissenson AR, Batlle D et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115:291-7.
4. Cheigh JS, Milite C, Sullivan JF et al. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 1992; 19:453-9.
5. Salem MM. Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis. 1995; 26:461-8.
6. Foley RN, Parfrey PS, Harnett JD et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996; 49:1379-85.
7. U.S. Renal Data System. USRDS 2002 annual data report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
8. Rahman M, Dixit A, Donley V et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 1999; 33:498-506.
9. Rahman M, Fu P, Sehgal AR et al. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis. 2000; 35:257-65.
10. Sehgal AR, Grey SF, DeOreo PB et al. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997; 30:41-9.
11. Perloff D, Grim C, Flack J et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993; 88:2460-70.
12. Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Dis. 1998; 32:S120-41.
13. Kotchen JM, Shakoor-Abdullah B, Walker W et al. Planning for a community-based hypertension control program in the inner city. J Hum Hypertens. 1996; 10 (suppl 3):S9-13.
14. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:67-74.
15. Morrell RW, Park DC, Kidder DP et al. Adherence to antihypertensive medications across the life span. Gerontologist. 1997; 37:609-19.
16. Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J Fam Pract. 1992; 35:61-5.
17. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-72.
18. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157:2413-46.
19. Horl MP, Horl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002; 39:227-44.
20. The USRDS Dialysis Morbidity and Mortality Study: wave 2. United States Renal Data System. Am J Kidney Dis. 1997; 30:S67-85.
21. Raine AE, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant. 1992; 7(suppl 2):7-35.
22. Salem MM, Bower J. Hypertension in the hemodialysis population: any relation to one-year survival? Am J Kidney Dis. 1996; 28:737-40.
23. Salem MM, Hypertension in the haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant. 1999; 14:125-8.
24. Agarwal R, Lewis R, Davis JL et al. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. Am J Kidney Dis. 2001; 38:1245-50.
25. Sica DA, Halstenson CE, Gehr TW et al. Pharmacokinetics and blood pressure response of losartan in end-stage renal disease. Clin Pharmacokinet. 2000; 38:519-26.
26. Cannella G, Paoletti E, Delfino R et al. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis. 1997; 30:659-64.
27. Kestenbaum B, Gillen DL, Sherrard DJ et al. Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int. 2002; 61:2157-64.
28. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 1998; 32:560-8.
29. Tozawa M, Iseki K, Iseki C et al. Analysis of drug prescription in chronic haemodialysis patients. Nephrol Dial Transplant. 2002; 17:1819-24.
30. Curtin RB, Svarstad BL, Keller TH. Hemodialysis patients' noncompliance with oral medications. ANNA J. 1999; 26:307-16.
31. Cleary DJ, Matzke GR, Alexander AC et al. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health-Syst Pharm. 1995; 52:1895-900.
32. Blanchard R, Berger W, Bailie GR et al. Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol. 1990; 34:173-8.
33. Agarwal R. Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int. 1999; 55:1528-35.
34. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999; 21:1074-90,
35. Lopot F, Kotyk P, Blaha J et al. Use of continuous blood volume monitoring to detect inadequately high dry weight. Int J Artif Organs. 1996; 19:411-4.